ComEd Reaches 99% Restoration Following Multi-Day Severe Storm Event

Crews in final stages of repairs following worst storms since 2020 and remain committed to completing service restoration for all customers CHICAGO–(BUSINESS WIRE)–ComEd crews have nearly completed the restoration of power to customers impacted by multiple rounds of severe storms that moved through northern Illinois beginning Wednesday afternoon. With 99% of affected customers now restored, …

CEL-SCI Corporation Announces Pricing of Offering

VIENNA, Va.–(BUSINESS WIRE)–$CVM #Multikine–CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a clinical stage cancer immunotherapy company, today announced the pricing of a best-efforts offering of 2,500,000 shares of common stock at an offering price of $1.00 per share. Total gross proceeds from the offering, before deducting the placement agent’s fees and offering expenses, …

Managing Tough Conversations: Lessons for CIOs Delivering Bad News

For chief information officers (CIOs), delivering difficult news is an inevitable part of the job. Project delays, budget overruns, cybersecurity incidents, and operational disruptions are part of the CIO role. The crucial aspect is how these issues are communicated. More importantly, it can influence executive confidence, organisational response, and long-term trust in technology leadership. The …

OECD Sees Global Growth Slipping Amid Escalating US-Iran Crisis

The Organisation for Economic Cooperation and Development (OECD) has revised downward its global economic growth projections, citing the escalating economic impact of the ongoing conflict between the United States and Iran. The organisation warned that the outlook could deteriorate further if a lasting peace agreement is not achieved in the near future. According to the …

GENESIS Pharma Expands Strategic Commercial Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics to the Nordic Region

The expanded partnership adds Denmark, Finland, Norway and Sweden to GENESIS Pharma’s existing network of thirteen Southeast European markets. It grants rights for the commercialization of Alnylam’s RNAi therapeutics for serious cardiomyopathy conditions and rare genetic diseases. ATHENS, Greece–(BUSINESS WIRE)–GENESIS Pharma, a leading regional biopharma company focused on the commercialization of innovative medicines in Europe, …

Coincheck Group Announces Completion of KDDI Strategic Investment

KDDI receives newly issued shares of Coincheck Group at $2.28 per share, an aggregate cash purchase price of $65 million, constituting 14.9% ownership of Coincheck Group’s outstanding ordinary shares AMSTERDAM–(BUSINESS WIRE)–Coincheck Group N.V. (NASDAQ: CNCK) (“Coincheck Group” or the “Company”), a Dutch public limited liability company that provides digital asset trade execution, custody, staking and …

GlobalFoundries and Qualinx Demonstrate First European Sovereign Manufacturing Flow for Security‑Critical Semiconductors

First end-to-end European chip manufacturing flow proven for aerospace, defense, IoT, consumer electronics and critical infrastructure DRESDEN, Germany & DELFT, Netherlands–(BUSINESS WIRE)–#ASIC—GlobalFoundries (GF) and Qualinx today announced the successful completion of the first fully European-based, end-to-end semiconductor manufacturing flow at GlobalFoundries’ Dresden fab on its FDX technology. The milestone demonstrates that security-critical chips for aerospace, …

Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE® (tocilizumab-bavi) in Cytokine Release Syndrome (CRS) and Pediatric COVID-19

JERSEY CITY, N.J.–(BUSINESS WIRE)–Organon (NYSE: OGN) today announced the US Food and Drug Administration (FDA) approval of the supplemental Biologics License Application (sBLA) for TOFIDENCE® (tocilizumab-bavi) injection, for intravenous use, a biosimilar to ACTEMRA (tocilizumab). The approval expands TOFIDENCE indications to include treatment of: (1) adults and pediatric patients 2 years of age and older …

Crownlands Releases Largest Open-Source Dataset of Living Patient Cells to Advance AI-Driven Research in Alzheimer’s and Neuroscience

Four million single cells from 200-plus donors capture human neuronal biology in tissue context, now accessible via the Chan Zuckerberg Initiative’s CZ CELLxGENE platform SAN FRANCISCO–(BUSINESS WIRE)–Crownlands, Inc., a company scaling the collection of living human neurons to generate molecular data for AI-driven drug discovery and clinical trial modeling, today announced the public release of …

Video Analytics & AI Integration: The Smart Eye of Modern Surveillance

Introduction As buildings and cities grow more complex, simply recording surveillance footage isn’t enough. What we need is intelligence—systems that can analyze, interpret, and act on what’s happening in real-time. That’s where Video Analytics and AI Integration steps in. From perimeter security and behavior analysis to traffic management and safety compliance, AI-powered video analytics is …